Growth • Johnson & Johnson
JNJ
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
1,6%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
1,1%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
-1,4%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
0,6%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
6,6%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
0,7%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!